Payam Moradian, of Keleti+Moradian LLP,  reviews  a notable changs in recent years in the U.S. patent practice that have been part of the institution of the Inter Partes Review procedure (IPR), which so far has resulted in a high number of U.S. patents being invalidated by the Patent Trial and Appeal Board (PTAB).

To read the full report, download the PDF.

Save

Save

Save

Save

Save

Save